跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Retatrime - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Retatrime
Approved
STANDARD
Retatrime
Zim Laboratories Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
19886789c6093476
Company
Zim Laboratories Ltd
Type
Standard
Approval Details
Approval Id
19886789c6093476
Drug Approval Philippines Name
Retatrime
Product Name
Retatrime
Registration Number
DRP-2479-06
Brand Name
Retatrime
Generic Name
Trimetazidine Hydrochloride
Dosage Form
Modified Release Film-Coated Tablet
Dosage Strength
35 mg
Manufacturer
Zim Laboratories Ltd
Importer
Suhitas Pharmaceuticals Inc.
Distributor
Reta Drug
Issuance Date
24 June 2024
Expiry Date
23 September 2025
Pharmacologic Category
Anti-anginal
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
19886789c6093476
Type
Standard
Back to Philippines FDA Approvals